AgomAb Therapeutics NV · NASDAQ:AGMB

AgomAb Therapeutics NV shareholders

As of Sep 30, 2026, 38 institutions reported holding AgomAb Therapeutics NV, 57.0% of its shares. Largest: EQT Fund Management S.a r.l., Sanofi and Cormorant Asset Management, LP. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of AgomAb Therapeutics NVChangeFiled
EQT Fund Management S.a r.l.5.14M10.4%newNov 12, 2026
Sanofi2.78M5.7%newNov 5, 2026
Cormorant Asset Management, LP2.47M5.0%newNov 16, 2026
Pfizer Inc2.15M4.4%newNov 12, 2026
TCG Crossover Management, LLC1.82M3.7%newNov 16, 2026
Nantahala Capital Management, LLC1.75M3.5%newNov 13, 2026
Redmile Group, LLC1.74M3.5%newNov 16, 2026
Federated Hermes, Inc.1.61M3.3%newNov 12, 2026
Casdin Capital, LLC1.55M3.1%newNov 16, 2026
Andera Partners1.54M3.1%newOct 16, 2026

AgomAb Therapeutics NV insider trades